Clin Drug Invest. 2004;24(12):695-717. Finally, subcutaneous insulin aspart every 1 or 2 hours was a well tolerated and cost-effective alternative to a standard intravenous protocol of regular ...

Enrollment of large, culturally diverse study populations allowed the examination ... their quota of patients was reached. Biphasic insulin aspart 30/70 was administered once, twice or three ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...

This partnership is in addition to Biocon Biologics’ own Insulin Aspart drug product, which is currently under review by the US Food and Drug Administration (FDA).

Under the terms of the agreement, Biocon Biologics will supply insulin aspart drug substance to Civica, who will use the drug substance to produce insulin aspart drug product, a rapid-acting insulin ...

Find all the commercial and brand names of generic drug called Insulin Aspart. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Under the terms of the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, Inc., who will use the drug substance to produce Insulin Aspart drug product, a rapid-acting ...